Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

Belsomra (suvorexant, MK-4305) Oral Tablets
Company:  Merck & Co., Inc.
Application No.:  204569
Approval Date: 8/13/2014

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.

 

Date created: September 12, 2014

Back to Top    Drugs@FDA

Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-